1. Market Research
  2. > Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*

Table Of Contents

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Novartis AG - Key Facts 6
Novartis AG - Key Employees 7
Novartis AG - Key Employee Biographies 9
Novartis AG - Major Products and Services 11
Novartis AG - Pharmaceutical Pipeline Products Data 14
Novartis AG, Pipeline Products by Therapy Area 14
Novartis AG, Pipeline Products by Development Phase 15
Novartis AG - History 38
Novartis AG - Company Statement 57
Novartis AG - Locations And Subsidiaries 58
Head Office 58
Other Locations and Subsidiaries 58
Section 2 - Company Analysis 79
Novartis AG - Business Description 79
Novartis AG - Corporate Strategy 80
Novartis AG - SWOT Analysis 81
SWOT Analysis - Overview 81
Novartis AG - Strengths 81
Novartis AG - Weaknesses 82
Novartis AG - Opportunities 83
Novartis AG - Threats 85
Novartis AG - Key Competitors 86
Section 3 - Company Financial Ratios 87
Financial Ratios - Capital Market Ratios 87
Financial Ratios - Annual Ratios 88
Performance Chart 90
Financial Performance 90
Financial Ratios - Interim Ratios 91
Financial Ratios - Ratio Charts 92
Section 4 - Company's Lifesciences Financial Deals and Alliances 93
Novartis AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 93
Novartis AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 94
Novartis AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 95
Novartis AG, Medical Equipment, Deals By Type, 2010 to YTD 2016 96
Novartis AG, Recent Deals Summary 97
Section 5 - Company's Recent Developments 98
Sep 15, 2016: Novartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress 98
Aug 12, 2016: 6 Novartis Korean executives indicted for bribing doctors 99
Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 100
May 25, 2016: Novartis highlights its strong foundation for long-term, sustainable growth at the third Meet Novartis Management event 106
May 24, 2016: COTA Increases Cross-Industry Support With the Addition of Celgene, Foundation Medicine HealthScape Advisors and Novartis as Strategic Investors 108
May 18, 2016: Novartis to present pivotal data in hematologic and solid tumor cancers at 2016 ASCO Annual Meeting 109
May 17, 2016: Novartis Foundation and partners launch innovative hypertension program in Vietnam 111
May 17, 2016: Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis 112
Apr 21, 2016: Novartis delivered solid Q1 despite Gleevec loss of exclusivity; investing behind new launches for long-term growth 113
Mar 31, 2016: Novartis publishes updated 2015 segment financials reflecting new division structure 118
Section 6 - Appendix 119
Methodology 119
Ratio Definitions 119
About GlobalData 123
Contact Us 123
Disclaimer 123

List of Tables
Novartis AG, Key Facts 6
Novartis AG, Key Employees 7
Novartis AG, Key Employee Biographies 9
Novartis AG, Major Products and Services 11
Novartis AG, Number of Pipeline Products by Therapy Area 14
Novartis AG, Number of Pipeline Products by Development Stage 15
Novartis AG, Pipeline Products By Therapy Area and Development Phase 16
Novartis AG, History 38
Novartis AG, Subsidiaries 58
Novartis AG, Key Competitors 86
Novartis AG, Ratios based on current share price 87
Novartis AG, Annual Ratios 88
Novartis AG, Interim Ratios 91
Novartis AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 93
Novartis AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 94
Novartis AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 95
Novartis AG, Medical Equipment, Deals By Type, 2010 to YTD 2016 96
Novartis AG, Recent Deals Summary 97
Currency Codes 119
Capital Market Ratios 119
Equity Ratios 120
Profitability Ratios 120
Cost Ratios 121
Liquidity Ratios 121
Leverage Ratios 122
Efficiency Ratios 122

List of Figures
Novartis AG, Pipeline Products by Therapy Area 14
Novartis AG, Pipeline Products by Development Phase 15
Novartis AG, Performance Chart (2011 - 2015) 90
Novartis AG, Ratio Charts 92
Novartis AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 93
Novartis AG, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 94
Novartis AG, Medical Equipment, Deals By Year, 2010 to YTD 2016 95
Novartis AG, Medical Equipment, Deals by Type, 2010 to YTD 2016 96

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.